147 related articles for article (PubMed ID: 36230829)
21. Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer.
Kanai K; Nakashima J; Sugawara A; Shigematsu N; Nagata H; Kikuchi E; Miyajima A; Nakagawa K; Kubo A; Oya M
Int J Clin Oncol; 2009 Dec; 14(6):502-6. PubMed ID: 19967485
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor.
Charret J; Baumann AS; Eschwege P; Moreau JL; Bernier V; Falk AT; Salleron J; Peiffert D
Brachytherapy; 2018; 17(6):888-894. PubMed ID: 30172752
[TBL] [Abstract][Full Text] [Related]
23. Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials.
Roy S; Loblaw A; Cheung P; Chu W; Chung HT; Vesprini D; Ong A; Chowdhury A; Panjwani D; Pang G; Korol R; Davidson M; Ravi A; McCurdy B; Helou J; Zhang L; Mamedov A; Deabreu A; Quon HC
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):621-629. PubMed ID: 31126725
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of PSA bounce after definitive radiotherapy revisited.
Urabe F; Kimura T; Sasaki H; Tashiro K; Iwatani K; Aoki M; Sato S; Takahashi H; Miki K; Egawa S
Int J Clin Oncol; 2022 Feb; 27(2):411-417. PubMed ID: 34677737
[TBL] [Abstract][Full Text] [Related]
25. PSA bouncing after brachytherapy HDR and external beam radiation therapy: a study of 121 patients with minimum 5-years follow-up.
Makarewicz R; Lebioda A; Terlikiewicz J; Biedka M; Wiśniewski T
J Contemp Brachytherapy; 2009 Jun; 1(2):92-96. PubMed ID: 27795718
[TBL] [Abstract][Full Text] [Related]
26. Prostate-specific antigen bounce after high-dose-rate monotherapy for prostate cancer.
Mehta NH; Kamrava M; Wang PC; Steinberg M; Demanes J
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):729-33. PubMed ID: 23582852
[TBL] [Abstract][Full Text] [Related]
27. Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.
Hinnen KA; Monninkhof EM; Battermann JJ; van Roermund JG; Frank SJ; van Vulpen M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):883-8. PubMed ID: 21300477
[TBL] [Abstract][Full Text] [Related]
28. PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation.
McGrath SD; Antonucci JV; Fitch DL; Ghilezan M; Gustafson GS; Vicini FA; Martinez AA; Kestin LL
Brachytherapy; 2010; 9(2):137-44. PubMed ID: 19850537
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer.
Naghavi AO; Strom TJ; Nethers K; Cruz AA; Figura NB; Shrinath K; Yue B; Kim J; Biagioli MC; Fernandez DC; Heysek RV; Wilder RB
Int J Clin Oncol; 2015 Jun; 20(3):598-604. PubMed ID: 25193155
[TBL] [Abstract][Full Text] [Related]
30. Relationship between sexual function and prostate-specific antigen bounce after iodine-125 permanent implant brachytherapy for localized prostate cancer.
Nishihara K; Nakiri M; Chikui K; Suekane S; Matsuoka K; Hattori C; Ogo E; Abe T; Matsumoto Y; Ishitake T
Int J Urol; 2014 Jul; 21(7):658-63. PubMed ID: 24650159
[TBL] [Abstract][Full Text] [Related]
31. Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients.
Leduc N; Atallah V; Creoff M; Rabia N; Taouil T; Escarmant P; Vinh-Hung V
Brachytherapy; 2015; 14(6):826-33. PubMed ID: 26489920
[TBL] [Abstract][Full Text] [Related]
32. Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?
Kataria S; Koneru H; Guleria S; Danner M; Ayoob M; Yung T; Lei S; Collins BT; Suy S; Lynch JH; Kole T; Collins SP
Front Oncol; 2017; 7():157. PubMed ID: 28791252
[TBL] [Abstract][Full Text] [Related]
33. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.
Toledano A; Chauveinc L; Flam T; Thiounn N; Solignac S; Timbert M; Rosenwald JC; Cosset JM
Brachytherapy; 2006; 5(2):122-6. PubMed ID: 16644467
[TBL] [Abstract][Full Text] [Related]
34. Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounce.
Quivrin M; Loffroy R; Cormier L; Mazoyer F; Bertaut A; Chambade D; Martin E; Maingon P; Walker P; Créhange G
Radiother Oncol; 2015 Nov; 117(2):258-61. PubMed ID: 26324019
[TBL] [Abstract][Full Text] [Related]
35. Time to achieve a prostate-specific antigen nadir of ≤0.2 ng/mL and related factors after permanent prostate brachytherapy.
Soyano T; Yorozu A; Natsume N; Hanada T; Shiraishi Y; Toya K; Saito S
Brachytherapy; 2021; 20(1):29-37. PubMed ID: 32814663
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Lief JH; Hinerman-Mulroy A; Galbreath RW
Brachytherapy; 2003; 2(3):181-8. PubMed ID: 15062141
[TBL] [Abstract][Full Text] [Related]
37. Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients.
Romesser PB; Pei X; Shi W; Zhang Z; Kollmeier M; McBride SM; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):59-67. PubMed ID: 29254782
[TBL] [Abstract][Full Text] [Related]
38.
Kindts I; Stellamans K; Billiet I; Pottel H; Lambrecht A
Strahlenther Onkol; 2017 Sep; 193(9):707-713. PubMed ID: 28488030
[TBL] [Abstract][Full Text] [Related]
39. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.
Critz FA; Williams WH; Levinson AK; Benton JB; Schnell FJ; Holladay CT; Shrake PD
J Urol; 2003 Nov; 170(5):1864-7. PubMed ID: 14532794
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer.
Darwis NDM; Oike T; Kawamura H; Kawahara M; Kubo N; Sato H; Miyasaka Y; Katoh H; Ishikawa H; Matsui H; Miyazawa Y; Ito K; Suzuki K; Gondhowiardjo S; Nakano T; Ohno T
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32143495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
